NBIX
Neurocrine Biosciences, Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$129.78
+2.00 ▲ +1.57%
🌙 3월 13일 5:41 PM ET (한국 3/14 06:41)
$127.26
-2.52 ▼ -1.94%
| Index | - | P/E | 27.81 | EPS (ttm) | 4.67 | Insider Own | 2.73% | Shs Outstand | 0.10B | Perf Week | 1.29% |
| Market Cap | 13.03B | Forward P/E | 16.87 | EPS next Y | 30.06% | Insider Trans | -3.56% | Shs Float | 0.10B | Perf Month | -5.57% |
| Enterprise Value | 12.02B | PEG | 0.58 | EPS next Q | 1.15 | Inst Own | 98.84% | Short Float | 3.46% | Perf Quarter | -16.61% |
| Income | 0.48B | P/S | 4.55 | EPS this Y | 26.65% | Inst Trans | 1.8% | Short Ratio | 2.96 | Perf Half Y | -9.62% |
| Sales | 2.86B | P/B | 3.99 | EPS next 5Y | 29% | ROA | 11.13% | Short Interest | 3.38M | Perf YTD | -8.5% |
| Book/sh | 32.5 | P/C | 8.8 | EPS past 3/5Y | 44.05% 2.31% | ROE | 16.38% | 52W High | -18.98% ($160.18) | Perf Year | 19.08% |
| Cash/sh | 14.75 | P/FCF | 17.4 | Sales past 3/5Y | 24.32% 22.29% | ROIC | 13.05% | 52W Low | 54.08% ($84.23) | Perf 3Y | 37.42% |
| Dividend Est. | - | EV/EBITDA | 18.03 | EPS Y/Y TTM | 41.73% | Gross Margin | 98.18% | Volatility(W/M) | 2.2% 2.84% | Perf 5Y | 33.71% |
| Dividend TTM | - | EV/Sales | 4.2 | Sales Y/Y TTM | 21.45% | Oper. Margin | 22.25% | ATR (14) | 3.54 | Perf 10Y | 266.2% |
| Dividend Ex-Date | - | Quick Ratio | 3.3 | EPS Q/Q | 47.94% | Profit Margin | 16.73% | RSI (14) | 46.06 | Recom | 1.42 |
| Dividend Gr. 3/5Y | - | Current Ratio | 3.39 | Sales Q/Q | 28.33% | SMA20 | 0.06% ($129.7) | Beta | 0.37 | Target Price | $177.57 |
| Payout | - | Debt/Eq | 0.14 | Earnings | 2000000 | SMA50 | -2.85% ($133.59) | Rel Volume | 0.83 | Prev Close | $127.78 |
| Employees | 2000 | LT Debt/Eq | 0.13 | EPS/Sales Surpr. | -17.97% 1.9% | SMA200 | -5.14% ($136.81) | Avg Volume(3M) | 1.14M | Price | $129.78 |
| IPO | 1996/5/23 | Option/Short | Yes/Yes | Trades | 14360 | Volume | 947,832 | Change | 1.57% |
뉴스 로딩 중...